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Abstract — A compact implantable printed meandered 
folded dipole antenna with a volume of 101.8 mm3 and robust 
performance is presented for operation in the 2.4 GHz medical 
ISM bands. The implant antenna is shown to maintain its 
return loss performance in the 2360 – 2400 MHz, 2400 – 2483.5 
MHz and 2483.5 – 2500 MHz frequency bands, simulated in 
eleven different body tissue types with a broad range of 
electrical properties. Bandwidth and resonant frequency 
changes are reported for the same antenna implanted in high 
water content tissues such as muscle and skin as well as low 
water content tissues such as subcutaneous fat and bone. The 
antenna was also shown to maintain its return loss 
performance as it was moved towards a tissue boundary within 
a simulated phantom testbed. 
Index Terms— Medical body area network; implantable 
medical devices; implanted antenna; body phantom; 
I. INTRODUCTION 
Interest in Implantable Medical Devices (IMDs) has 
continued to rise, especially with the deployment of the 
Medical Body Area Network (MBAN) devices in the 2360 – 
2400 MHz band, licensed by the Federal Communications 
Commission (FCC) [1] and the 2483.5–2500 MHz band by 
the European Telecommunications Standards Institute 
(ETSI) [2] in 2012. This is primarily due to the potential 
impact that IMDs could have on clinical applications, for 
example, the ability to obtain real-time biotelemetric data on 
a patient to enhance their diagnosis and treatment [3]. 
In the past, bulky, near field magnetic induction based 
technologies were the dominant method for communication 
between an in-body IMD and an external receiver [4]. A 
need for higher data rates and longer communication 
distances seen the introduction of the Medical Implant 
Communication Service (MICS) band (402 – 405 MHz) in 
1999. Narrowband radio became the dominant method for 
IMD communication with many implant antennas designed 
to work within this band [5]. 
Reducing the overall volume of the implant device is 
one of the primary design goals for clinical applications. 
Many in-body implants are now battery powered as it 
increases functionality, therefore, having a more efficient 
wireless system gives the possibility of reduced battery 
volume or longer implant life with conservative power 
management. Compact and efficient implant antenna design 
is one of the most challenging issues for implants. One 
solution to reduce antenna size is to increase the operating 
frequency of the system. However, propagation losses in 
biological tissues increase with frequency, which reduces 
the overall efficiency of the system. Some losses can be 
countered by the gains in the efficiency of compact antennas 
as their electrical size increases [6]. This approach has been 
adopted and several implant antennas have been designed 
which operate in the 2400 – 2483.5 MHz Industrial 
Scientific Medical (ISM) band [7]. 
It is understood that an implant antenna’s performance 
is strongly affected by the type of tissue that surrounds it [8] 
with potential radiation pattern distortion, reduced radiation 
efficiency and changes in antenna input impedance [9]. 
However, how much the antenna is affected is heavily 
dependent on the nature of the tissue in close proximity to 
the antenna and an ideal antenna would maintain its 
performance in the presence of all expected tissue types.  
Tissue types can be classified into two main groups. 
The first are low water content tissue, which have relatively 
low permittivity and low conductivity such as bone and fats. 
The second are high water content tissue, which have higher 
permittivity and conductivity such as muscle and skin [10]. 
As the conductivity of the tissue around a given antenna 
changes, so too will the bandwidth, radiation pattern and 
radiation efficiency. Likewise, as the permittivity of the 
surrounding tissue changes, the wavelength within that 
tissue type changes, resulting in a resonant frequency shift 
of the implanted antenna [8]. 
While having relatively high dielectric material 
surrounding the antenna is advantageous when physically 
small antennas are required, this property cannot always be 
exploited successfully for in-body antennas, but instead can 
be a huge disadvantage. The human body is made up of a 
number of different tissues with different dielectric 
properties. The distribution, amount and exact dielectric 
properties of these tissues vary from person to person. An 
antenna designed for one tissue in one subject may not be 
suitable for another tissue or subject [5]. 
Previous work investigated the detuning effects on a 
MICS band antenna at different locations within the body 
and found a maximum detuning of 49 MHz and impedance 
mismatch difference of 22.6 dB from a reference 
performance in mean body tissue [11]. For an antenna to 
perform sufficiently at any location within the body, its 
performance must be robust enough to withstand any 
resonant frequency or bandwidth change that its current 
location may present. Therefore we present a compact, 
implantable antenna that sufficiently maintains its 
performance when implanted inside a broad range of 
 different tissues or when placed close to tissue boundaries. 
The target operating bands are 2360 – 2400 MHz (US), 
2400 – 2483.5 MHz (worldwide) and 2483.5 – 2500 MHz 
(EU). Section II details the antenna and the numerical test 
procedure used to evaluate its performance. Section III 
examines the results from the tests and the report concludes 
with a summary of the findings and suggestions for further 
work. 
II. ANTENNA & TEST SETUP 
Typical implant tissue types listed in Table 1 were 
used within a numerical test bed. It is intuitive to expect that 
there will be a contrast in antenna performance between the 
high permittivity tissues such as muscle, stomach and skin 
in comparison to tissues with lower permittivity such as 
bone and Subcutaneous Adipose Tissue (SAT). In terms of 
propagation, the most problematic tissues are those with 
high conductivity and permittivity as the field attenuation is 
greatest.  
TABLE 1 – DIELECTRIC PROPERTIES OF CHOSEN TISSUES AT 2.38 
GHZ [12] 
To overcome the challenges associated with variable 
tissue properties, the antenna is required to have a wide 
impedance bandwidth to maintain an in-band return loss 
of -10 dB (VSWR =2) despite the resonant frequency shifts 
caused by the changing relative permittivity of the 
surrounding tissues. However, this is further compounded as 
tissue conductivity also decreases with permittivity between 
high and low water content tissues, changing the bandwidth 
of the antenna. 
Another solution would be to design an antenna which 
has multiple resonances which would resonate as the 
antenna moves between different tissue types, maintaining 
the in-band return loss target value of -10 dB. 
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Figure 1- Antenna Geometry 
 
The proposed antenna (Figure 1) is 16.7mm x 
5.375mm with a volume of 101.833mm
3
, making it suitable 
for implantation [8] with comparable size to the antennas 
reviewed in [13]. Rogers RT/duroid 6010 (εr = 10.8, σ = 
0.0014), suitable for prototyping, was used as the substrate 
and superstrate materials and the antenna is coaxial probe 
fed. In the case of an antenna embedded within lossy media, 
the near field couples strongly with the surrounding 
material, thereby decreasing radiation efficiency [14]. To 
reduce this effect, a high permittivity substrate and 
superstrate are used to concentrate as much of the near field 
as possible within the low loss dielectric, rather than the 
lossy surrounding tissue. Although this material is not 
biocompatible, it does have similar dielectric properties to 
the biocompatible ceramic alumina 99.5% (εr = 9.8, σ = 
1.0904e-7). 
The Finite Difference Time Domain (FDTD) software 
Sim4Life by Zurich MedTech was used to simulate the 
antenna performance in various tissue types. The antenna 
model was placed in the centre of a 110mm x 110mm x 
110mm cube. The size of the cube was optimized so that the 
return loss performance was not influenced by its proximity 
to the media boundary for all tissue types. The model used 
can be seen below in Figure 2.  
 
Figure 2 - Simulated Antenna Tissue Testbed 
Tissue Type Relative 
Permittivity 
Conductivity 
(S/m) 
Stomach 62.3 2.15 
Small Intestine 54.6 3.12 
Kidney 52.9 2.37 
Muscle 52.8 1.69 
Brain 44.9 2.06 
Liver 43.2 1.64 
Skin 38.1 1.43 
Lung 
(Inflated) 
20.5 0.785 
Bladder 18 0.668 
Bone 11.4 0.381 
SAT 10.8 0.259 
 A second test for robust antenna performance is to 
investigate how the performance varies in proximity to 
boundaries between different tissue types. To do this, a 
second numerical phantom model was generated, replicating 
the shape of a layered human tissue phantom developed at 
Queen’s University Belfast [15] [16]. The nylon shell was 
replaced with SAT and skin layers, each with a thickness of 
2 mm, making a more realistic implant boundary condition. 
The inner core layer was filled with a muscle liquid, as in 
the original work. The antenna model was placed in the 
centre of the phantom and moved in ten 5 mm steps until the 
front surface of the superstrate came into contact with the 
SAT layer. S11 and radiation efficiency was observed for 
each step.  
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Figure 3 - Layered Phantom Testbed Model [15] 
III. RESULTS AND ANALYSIS 
Return loss and radiation efficiency are used as the 
primary metrics for evaluating relative antenna performance 
in each tissue type. Radiation efficiency is a common metric 
for implant performance. However, it is related to the 
volume and shape of the media, as well as the position of 
the antenna relative to a boundary. Nonetheless, the Total 
Radiation Efficiency (TRE) results can be used to compare 
the relative performance of the same antenna in different 
tissues, when the aforementioned factors are constant. The 
reflection coefficient and TRE for each tissue type is shown 
in Table 2. 
The results in Figure 4 and Table 2 show that the antenna 
maintains a return loss below -10 dB for the target 
frequency bands (frequency limits are highlighted by 
vertical lines in the figure) in all tissue types. As expected, 
the antenna had the highest resonant frequencies at 2.257 
and 2.968 GHz when embedded in SAT tissue, due to its 
relatively low permittivity. The antenna had the lowest 
resonant frequency in small intestine tissue despite this 
tissue not having the highest permittivity of the tissue types 
tested. This is due to small intestine tissue having the 
highest conductivity of the tissues tested, giving the antenna 
the largest bandwidth when embedded in it.  
 
Figure 4 - Graph of S11 vs Tissue Type 
*For 1mW input power over 1g tissue cubes 
TABLE 2- SIMULATED RESULTS FOR ANTENNA PLACED IN 
CENTRE OF VARIOUS TISSUE CUBES 
 The TRE of the antenna decreased as the conductivity 
of the tissue in increased. The antenna was most efficient 
when embedded in SAT and least efficient when embedded 
in small intestine tissue. The only exception to this was 
between skin and liver tissue, with the antenna being more 
efficient in skin despite it having a higher conductivity. This 
can be attributed to the antenna having a higher mismatch 
efficiency in skin despite having a slightly lower radiation 
efficiency when compared to liver, therefore producing a 
higher TRE. 
Specific Absorption Rate (SAR) is an important factor 
to take into consideration when designing implant antennas 
as patient safety is of the utmost importance. Peak spatial 
average SAR (psSAR) was calculated over 1g of tissue for 
each tissue type according to the IEEE/IEC62704-1  
standard with an input power of 1mW. As can be seen from 
Table 2, the psSAR never exceeds the recommended safety 
limit of 1.6 W/kg for all tissue types. 
Tissue  
Type 
Resonant 
Frequency 
(GHz) 
Return 
Loss 
(dB) 
-10 dB 
Bandwidth 
(GHz) 
TRE @ 
2.38 GHz 
(%) 
Peak Spatial 
Average SAR 
(W/kg)* 
Stomach 1.655, 
2.368 
-23.64, 
-31.79 
1.358 - 2.536 
(49.5%) 
0.0054 0.32 
Small 
Intestine 
1.625, 
2.385 
-27.68, 
-46.38 
1.306 - 2.567 
(52%) 
0.00025 0.419 
Kidney 1.649, 
2.394 
-27.94, 
-34.8 
1.345 - 2.566 
(51.3%) 
0.0019 0.359 
Muscle 1.676, 
2.394 
-26.06, 
-26.64 
1.386 - 2.556 
(49.2%) 
0.015 0.289 
Brain 1.672, 
2.421 
-35.35, 
-32.91 
1.364 - 2.592 
(51.5%) 
0.0032 0.351 
Liver 1.697, 
2.432 
-34.18, 
-27.35 
1.399 - 2.595 
(50.2%) 
0.011 0.305 
Skin 1.706, 
2.492 
-36.86, 
-42.68 
1.411 - 2.646 
(51.8%) 
0.017 0.289 
Lung 
(Inflated) 
1.932, 
2.65 
-24.31, 
-56.51 
1.634 - 2.805 
(49.2%) 
0.097 0.401 
Bladder 1.969, 
2.699 
-24.27, 
-21.84 
1.676 – 2.852 
(49.4%) 
0.16 0.254 
Bone 2.217, 
2.913 
-25.84, 
-17.77 
1.968 - 3.054 
(45.6%) 
1.04 0.174 
SAT 2.257, 
2.968 
-39.21, 
-20.06 
2.033 - 3.089 
(44.4%) 
2.81 0.193 
  
Figure 5 - Graph of S11 vs Displacement from Centre of Tissue 
Cube towards Tissue Boundary 
The tissue boundary investigative results can be seen 
in Figure 5. S11 was not affected until the antenna came to 
within 5 mm from the boundary. The greatest change was 
encountered when the antenna was placed up against the 
SAT layer boundary, causing a slight frequency and 
bandwidth change as the antenna near field encountered the 
lower permittivities and conductivities of the other layers. 
Nonetheless, the antenna maintained a return loss 
below -10dB for all target frequency bands for all antenna 
positions investigated from the centre of the phantom to the 
boundary between the muscle and SAT layers.  
 
IV. CONCLUSIONS AND FUTURE WORK 
A compact, implantable antenna for MBAN operation 
in the 2360 – 2400 MHz, 2400 – 2483.5 MHz and 2483.5 – 
2500 MHz bands is presented. The antenna maintains a 
return loss below -10 dB in eleven different tissues with a 
broad range of electrical properties (permittivity and 
conductivity). The antenna was also shown to maintain S11 
performance as the antenna moved from the centre of the 
numerical phantom testbed towards a tissue boundary. 
Further work will include prototyping and validating 
antenna performance using experimental measurements. 
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